This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 23:00, 22 October 2011 (Updating {{drugbox}} (changes to verified fields - updated 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or [[u...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:00, 22 October 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to verified fields - updated 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or [[u...)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Metabolism | Rapidly hydrolyzed to ampicillin |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H27N3O7S |
Molar mass | 465.519 g/mol g·mol |
(what is this?) (verify) |
Bacampicillin (INN) is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability.
It is sold under the brand names Spectrobid (Pfizer) and Penglobe (AstraZeneca).
References
- Bodin NO; Ekström B; Forsgren U; et al. (1975). "Bacampicillin: a New Orally Well-Absorbed Derivative of Ampicillin". Antimicrob Agents Chemother. 8 (5): 518–25. PMC 429411. PMID 1211909.
{{cite journal}}
: Unknown parameter|author-separator=
ignored (help); Unknown parameter|month=
ignored (help)
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |